A next step for nasal and ocular symptom control9
This online resource is designed to help healthcare professionals manage their patients with seasonal or perennial allergic rhinitis, who may benefit from Dymista® after monotherapy treatment has failed to control their symptoms.
Dymista® is the only combination of an intranasal corticosteroid (INS) and an intranasal antihistamine (INAH) available in a single device.6
Dymista® is clinically proven to relieve the symptoms of moderate to severe allergic rhinitis in head to head studies involving more than 4,600 patients.5,10,11
Dymista® is indicated for the relief of symptoms of moderate to severe seasonal and perennial allergic rhinitis if monotherapy with either intranasal antihistamine or glucocorticoid is not considered sufficient.6